Semaglutide lowers blood sugar levels by stimulating insulin secretion and reducing glucagon secretion, effectively controlling blood sugar in patients with type 2 diabetes. It can also be used to reduce the risk of heart disease, stroke, and even cancer in overweight/obese adults with cardiovascular conditions. In the field of weight loss, semaglutide also shows excellent results, significantly reducing the risk of major adverse cardiovascular events, including cardiovascular death and non-fatal myocardial infarction.
